Streetwise

Streetwise is an addiction-treatment facility located in Albuquerque, NM. The facility's programming is outpatient (Outpatient, Dual Dx), not residential. What follows is an orientation — not a review — to the practical questions worth asking before admission.

Care levels at Streetwise

Streetwise is an outpatient-focused program (Outpatient, Dual Dx) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. The useful move is to have an ASAM-aligned assessment done before admission — ideally by someone outside the facility's admissions team — to confirm that the level of care offered here is what the clinical picture calls for.

Insurance and payment

Streetwise accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The facility also accepts TRICARE or military benefits. What tends to produce post-admission financial surprise is not the facility being out of network — it is the verbal assurance that did not make it into writing. Ask for the written VOB before admission, save the email, and the rest of the financial conversation becomes a lot simpler.

Specialty programming

The facility's documented specialty programming includes: Young adults, Seniors or older adults, Veterans. If that matches what you or your family member need, great — and worth asking specifically about what the programming looks like day-to-day (how many hours per week of specialty-specific content, who leads it, what credentials they hold).

Before you call

The three questions that consistently separate programs worth considering from programs worth skipping: ASAM level of care match; written VOB for your plan; MAT policy. If the clinical situation involves opioid use disorder, confirm explicitly whether Streetwise offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care. Programs that cannot answer all three quickly are programs worth approaching with caution.